The primary focus of these studies is on the role of the glial-derived protein, S100B, in inducing neuronal cell death through the activation of glia following perinatal hypoxia-ischemia (HI). The term 'glial activation' is used to define the process by which glia, especially astrocytes and microglia, respond to insults, injury, or alterations in their environment. Activated glia shows pro-inflammatory cytokines and oxidative stress enzymes. Cell-based and clinical studies have implicated S100B in the initiation and maintenance of a pathologic state of glial activation culminating in neuronal death. A working model based on cell culture experiments, for the sequence of glial activation can be summarized as: S100B --> TNF alpha and IL-11 beta released from microglia --> iNOS induction in astrocytes --> NO generation and neuronal death. Whether this process is recapitulated in vivo is a principal focus of the proposed studies. Our preliminary in vivo data, other cell-based data and clinical observation suggests that S100B is released in response to brain injury and that elevated S100B levels initiate a pathologic process of glial activation culminating in neuronal death or dysfunction. Our hypothesis is that hypoxia-ischemia (HI) in the newborn mouse brain leads to increased glial release of S100B resulting in an increase in glial activation and enhancement of neuronal injury. Our preliminary data suggest that transgenic mice which over-express the S100B protein are more vulnerable to HI injury, showing increased mortality and infarct size.
Our specific Aims are: 1) Characterize the pro-inflammatory glial response after HI using histochemical and molecular techniques; 2) Elucidate the role of St00B in the mechanism of glial-dependent neurologic injury after HI using MRI and immunohistochemical methods; and 3) Determine the effects of pharmacologic inhibition of glial activation on neurologic injury in wild type, S100B transgenic and knockout mice using novel bioavailable protein kinase inhibitors. The convergent pharmacological and genetic approaches to understanding the mechanisms of glial activation in acute brain injury may lead to the identification of new therapeutic targets in perinatal asphyxia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08NS044998-04
Application #
7222665
Study Section
NST-2 Subcommittee (NST)
Program Officer
Hicks, Ramona R
Project Start
2004-03-15
Project End
2009-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
4
Fiscal Year
2007
Total Cost
$164,156
Indirect Cost
Name
Children's Memorial Hospital (Chicago)
Department
Type
DUNS #
074438755
City
Chicago
State
IL
Country
United States
Zip Code
60611
Rossi, Janet L; Ralay Ranaivo, Hantamalala; Patel, Fatima et al. (2011) Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase. J Neurosci Res 89:852-61
Venkatesan, Charu; Chrzaszcz, MaryAnn; Choi, Nicole et al. (2010) Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflammation 7:32
Ralay Ranaivo, Hantamalala; Wainwright, Mark S (2010) Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways. Brain Res 1313:222-31
Chrzaszcz, MaryAnn; Venkatesan, Charu; Dragisic, Tina et al. (2010) Minozac treatment prevents increased seizure susceptibility in a mouse ""two-hit"" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures. J Neurotrauma 27:1283-95
Somera-Molina, Kathleen C; Nair, Sangeetha; Van Eldik, Linda J et al. (2009) Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res 1282:162-72
Venkatesan, Charu; Wainwright, Mark S (2008) Pediatric endocarditis and stroke: a single-center retrospective review of seven cases. Pediatr Neurol 38:243-7
Lloyd, Eric; Somera-Molina, Kathleen; Van Eldik, Linda J et al. (2008) Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation 5:28
Wainwright, Mark S; Grundhoefer, Dava; Sharma, Shruti et al. (2007) A nitric oxide donor reduces brain injury and enhances recovery of cerebral blood flow after hypoxia-ischemia in the newborn rat. Neurosci Lett 415:124-9
Somera-Molina, Kathleen C; Robin, Beverley; Somera, Cherie Ann et al. (2007) Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 48:1785-800
Rossi, Janet L; Velentza, Anastasia V; Steinhorn, David M et al. (2007) MLCK210 gene knockout or kinase inhibition preserves lung function following endotoxin-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 292:L1327-34

Showing the most recent 10 out of 13 publications